These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38803437)

  • 1. Advancing crush syndrome management: the potent role of Sodium zirconium cyclosilicate in early hyperkalemia intervention and survival enhancement in a rat model.
    Li D; Zhang Y; Chen Y; Yang B; Chen J; Shi J; Guo X; Liu Y; Zhang L; Lv Q; Fan H
    Front Pharmacol; 2024; 15():1381954. PubMed ID: 38803437
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis.
    Zhang Y; Xu R; Wang F; Liu Y; Xu J; Zhao N; Cheng F; Long L; Jia J; Lin S
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):1057-1066. PubMed ID: 33459923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum potassium response to single-dose sodium zirconium cyclosilicate for the treatment of asymptomatic hyperkalemia in hospitalized patients.
    Lewis H; Stamper B; Yungkurth AC
    Pharmacotherapy; 2024 Jan; 44(1):13-21. PubMed ID: 37475499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Dose of Sodium Zirconium Cyclosilicate Versus Sodium Polystyrene Sulfonate in Hospitalized Patients With Hyperkalemia.
    Yoo N; Song YB; Dubinsky I; Altshuler J
    Ann Pharmacother; 2023 Sep; 57(9):1044-1052. PubMed ID: 36637028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIALIZE China: A Phase IIIb, Randomized, Placebo-Controlled Study to Reduce Predialysis Hyperkalemia With Sodium Zirconium Cyclosilicate in Chinese Patients.
    Ni Z; Lu R; Xu X; Bian X; Zhou Z; Yang J; Luo Q; Chen M; Chen C; Sun X; Yu L; He Q; Jiang H; Yuan W; Li Y; Zhou R; Wang J; Zhang X; Zuo L; Meng X; Chang Z; Zhao J; Wessman P; Xiang P;
    Clin Ther; 2023 Jul; 45(7):633-642. PubMed ID: 37385905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Patiromer and Sodium Zirconium Cyclosilicate on Blood Pressure in Rats with Chronic Kidney Disease.
    Li L; Budden J; Quinn CM; Bushinsky D
    J Cardiovasc Pharmacol Ther; 2024; 29():10742484241227580. PubMed ID: 38311939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose-response, phase 2/3 study.
    Kashihara N; Nishio T; Osonoi T; Saka Y; Imasawa T; Ohtake T; Mizuno H; Shibagaki Y; Kim H; Yajima T; Sarai N
    Clin Exp Nephrol; 2020 Dec; 24(12):1144-1153. PubMed ID: 32779057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Real-World Experience of Hyperkalemia Management Using Sodium Zirconium Cyclosilicate in Chronic Hemodialysis: A Multicenter Clinical Audit.
    Qu X; Hua Y; Khan BA
    Cureus; 2023 Sep; 15(9):e45058. PubMed ID: 37829953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of sodium zirconium cyclosilicate for the management of acute and chronic hyperkalemia in children with chronic kidney disease 4-5 and on dialysis.
    Khandelwal P; Shah S; McAlister L; Cleghorn S; King L; Shroff R
    Pediatr Nephrol; 2024 Apr; 39(4):1213-1219. PubMed ID: 37857905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials.
    Roger SD; Spinowitz BS; Lerma EV; Fishbane S; Ash SR; Martins JG; Quinn CM; Packham DK
    Nephrol Dial Transplant; 2021 Apr; 36(5):871-883. PubMed ID: 32588050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
    Fishbane S; Ford M; Fukagawa M; McCafferty K; Rastogi A; Spinowitz B; Staroselskiy K; Vishnevskiy K; Lisovskaja V; Al-Shurbaji A; Guzman N; Bhandari S
    J Am Soc Nephrol; 2019 Sep; 30(9):1723-1733. PubMed ID: 31201218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HARMONIZE Asia: A Phase III Randomized Study to Investigate the Efficacy and Safety of Sodium Zirconium Cyclosilicate in Patients with Hyperkalemia in China.
    Liang X; Lu W; Yu X; Cheng H; He Q; Peng Q; Ni Z; Long G; Wang L; Chen W; Li R; Zhao J; Zhang Y; Lisovskaja V; Tang Z
    Clin Ther; 2024 Sep; 46(9):702-710. PubMed ID: 39112102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia.
    Takkar C; Nassar T; Qunibi W
    Expert Opin Pharmacother; 2021 Jan; 22(1):19-28. PubMed ID: 32892634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-Analysis.
    Shrestha DB; Budhathoki P; Sedhai YR; Baniya R; Cable CA; Kashiouris MG; Dixon DL; Kidd JM; Adhikari Y; Marasini A; Bhandari S
    Curr Ther Res Clin Exp; 2021; 95():100635. PubMed ID: 34367383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium-lowering effects of sodium zirconium cyclosilicate in the early post-transplant period.
    Shockey W; Wiegel JJ; Parajuli S; Garg N; Swanson KJ; Mandelbrot DA
    Clin Transplant; 2024 Jan; 38(1):e15156. PubMed ID: 37812572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of patiromer vs sodium zirconium cyclosilicate for the treatment of hyperkalemia in Spain and the UK.
    Ramirez de Arellano A; Jakutis G; Hunt B
    J Med Econ; 2024; 27(1):1011-1017. PubMed ID: 39023516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double-blind, Placebo-controlled Study (ENERGIZE).
    Peacock WF; Rafique Z; Vishnevskiy K; Michelson E; Vishneva E; Zvereva T; Nahra R; Li D; Miller J
    Acad Emerg Med; 2020 Jun; 27(6):475-486. PubMed ID: 32149451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients.
    Sullivan E; Ruegger M; Dunne I; Sutaria N; Towers WF
    Am J Health Syst Pharm; 2023 Sep; 80(18):1238-1246. PubMed ID: 37335862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study.
    Yao L; Xing X; Li Y; Zhang F; Li P; Liang X; Wang P
    J Transl Med; 2022 Jul; 20(1):333. PubMed ID: 35879718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE.
    Fishbane S; Ford M; Fukagawa M; McCafferty K; Rastogi A; Spinowitz B; Staroselskiy K; Vishnevskiy K; Lisovskaja V; Al-Shurbaji A; Guzman N; Bhandari S
    BMC Nephrol; 2022 Feb; 23(1):59. PubMed ID: 35135481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.